Thrombolysis for acute ischaemic stroke: current status and future perspectives
Alteplase is currently the only approved thrombolytic agent for treatment of acute ischaemic
stroke, but interest is burgeoning in the development of new thrombolytic agents for systemic …
stroke, but interest is burgeoning in the development of new thrombolytic agents for systemic …
Clinically ineffective reperfusion after endovascular therapy in acute ischemic stroke
Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large
vessel occlusion. However, in clinical practice, nearly half of the patients do not have …
vessel occlusion. However, in clinical practice, nearly half of the patients do not have …
Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint …
Background The optimum systolic blood pressure after endovascular thrombectomy for
acute ischaemic stroke is uncertain. We aimed to compare the safety and efficacy of blood …
acute ischaemic stroke is uncertain. We aimed to compare the safety and efficacy of blood …
Adjunctive intravenous Argatroban or Eptifibatide for ischemic stroke
Background Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The
efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant …
efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant …
Endovascular management of acute stroke
Stroke related to large vessel occlusion is a leading cause of disability and death worldwide.
Advances in endovascular therapy to reopen occluded arteries have been shown to reduce …
Advances in endovascular therapy to reopen occluded arteries have been shown to reduce …
No-reflow phenomenon in stroke patients: a systematic literature review and meta-analysis of clinical data
Background: The no-reflow phenomenon refers to the absence of microvascular reperfusion
despite macrovascular reperfusion. Aim: The aim of this analysis was to summarize the …
despite macrovascular reperfusion. Aim: The aim of this analysis was to summarize the …
[HTML][HTML] Risk factors, pathophysiologic mechanisms, and potential treatment strategies of futile recanalization after endovascular therapy in acute ischemic stroke
G Deng, Y Chu, J **ao, K Shang, LQ Zhou… - Aging and …, 2023 - ncbi.nlm.nih.gov
Endovascular therapy is the first-line treatment for acute ischemic stroke. However, studies
have shown that, even with the timely opening of occluded blood vessels, nearly half of all …
have shown that, even with the timely opening of occluded blood vessels, nearly half of all …
Acute ischaemic stroke: recent advances in reperfusion treatment
P Widimsky, K Snyder, J Sulzenko… - European Heart …, 2023 - academic.oup.com
Abstract During the last 5–7 years, tremendous progress was achieved in the reperfusion
treatment of acute ischaemic stroke during its first few hours from symptom onset. This …
treatment of acute ischaemic stroke during its first few hours from symptom onset. This …
Endovascular thrombectomy for basilar artery occlusion: translating research findings into clinical practice
Background Basilar artery occlusion is a rare and severe condition. The effectiveness of
endovascular thrombectomy in patients with basilar artery occlusion was unclear until …
endovascular thrombectomy in patients with basilar artery occlusion was unclear until …
No-reflow post-recanalization in acute ischemic stroke: mechanisms, measurements, and molecular markers
Acute ischemic stroke remains the primary cause of disability worldwide. For patients with
large vessel occlusions, intravenous thrombolysis followed by mechanical thrombectomy …
large vessel occlusions, intravenous thrombolysis followed by mechanical thrombectomy …